Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (51)

2024

  1. Comparison between beta-blockers and calcium channel blockers in patients with atrial fibrillation according to renal function

    Clinical Cardiology, Vol. 47, Núm. 5

  2. Liver fibrosis and outcomes of atrial fibrillation: the FIB-4 index

    Clinical Research in Cardiology, Vol. 113, Núm. 2, pp. 313-323

  3. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651

  4. Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction

    Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004404

2023

  1. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis

    Trends in Cardiovascular Medicine, Vol. 33, Núm. 5, pp. 319-326

  2. Bleeding and embolic risk in patients with atrial fibrillation and cancer

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 344-352

  3. Comparison of Stroke and Bleeding Risk Profile in Patients With Atrial Fibrillation and Chronic Kidney Disease

    American Journal of Cardiology, Vol. 196, pp. 31-37

  4. Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo

    JACC: Cardiovascular Imaging, Vol. 16, Núm. 12, pp. 1567-1580

  5. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study

    European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360

  6. Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry

    Revista Portuguesa de Cardiologia, Vol. 42, Núm. 3, pp. 237-246

  7. Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 555-563

2022

  1. Nutrition status, obesity and outcomes in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 826-833

  2. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  3. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

  4. Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort

    International Journal of Cardiology, Vol. 367, pp. 90-98

  5. Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342

2021

  1. Acute myocardial infarction with high Killip class: Do geographic differences matter?

    European Heart Journal: Acute Cardiovascular Care

  2. Baseline CHA2DS2-VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome

    International Journal of Clinical Practice, Vol. 75, Núm. 6

  3. Glycated Hemoglobin and Subclinical Atherosclerosis in People Without Diabetes

    Journal of the American College of Cardiology, Vol. 77, Núm. 22, pp. 2777-2791

  4. Synergistic Impact of Systolic Blood Pressure and Perfusion Status on Mortality in Acute Heart Failure

    Circulation. Heart failure, Vol. 14, Núm. 3, pp. e007347